Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532998 | NSE Symbol : LOTUSEYE | ISIN : INE947I01017 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
13-Feb-2025	12-Feb-2025	Quarterly Results	Newspaper advertisement of the financial results approved by the Board in its meeting held on 12.02.2025 The Board of directors in its meeting held on 12.02.2025 approved the unaudited standalone financial results for the quarter and year ended 31.12.2024 (As Per BSE Announcement dated on 12.02.2025)
04-Nov-2024	12-Nov-2024	Half Yearly Results	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve consideration of unaudited standalone financial results for the half year and period ended September 30th 2024. approval of unaudited standalone financial results (As Per BSE Announcement Dated on: 12/11/2024)
12-Aug-2024	12-Aug-2024	Quarterly Results	The Board of directors of the company at its meeting held on 12th august approved the unaudited standalone results for the quarter and financial year ended June 30th 2024
27-May-2024	27-May-2024	Quarterly Results	The Board of Directors of Lotus Eye Hospital and Institute Limited approved the audited standalone financial results for the quarter and financial year ended 31st March 2024 The Board of Directors wishes to tell the shareholders that we are not considering Final dividend this time considering the expansion plans of the company but we assure the shareholders that we will be considering an interim dividend during the financial year 2024-25 The Board of directors of Lotus Eye Hospital and Institute Limited approved the audited financial results for the quarter and financial year ended 31st march 2024 (As Per BSE Announcement Dated on 27.05.2024)
24-Jan-2024	14-Feb-2024	Accounts	LOTUS EYE HOSPITAL AND INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 14 Feb 2024 to consider financial statements for the period ended December 2024. Financial results. Approved unaudited standalone results for the quarter and period ended December 31st 2023 (As per BSE Announcement Dated on 14/02/2024)
27-Oct-2023	14-Nov-2023	Accounts	LOTUS EYE HOSPITAL AND INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 14 Nov 2023 to consider financial statements for the period ended September 2023. Financial results. Approved unaudited standalone results for the quarter and period ended 30th September 2023 (As Per BSE Announcement dated on 14.11.2023) Of financial results approved by the Board of directors in its meeting held on 14th November 2023 (As Per BSE Announcement dated on 16.11.2023)
29-Jul-2023	14-Aug-2023	Quarterly Results	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Un Audited Standalone Financial Results of the company for the quarter and the period ended June 30 2023. In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on August 14, 2023has transacted the following business: 1) Approved unaudited standalone results for the quarter and period ended June 30th, 2023; 2) Approved the appointment of Ms Sangeetha Sundaramoorthy for a term of 5 years and revision in remuneration subject to approval of shareholders in the next general meeting (As Per BSE Announcement dated on 14.08.2023) This is in continuation to our announcement dated 14th August 2023 in which sangeetha sundaramoorthy was appointed as the Managing Director of Lotus Eye Hospital and Institute Limited for a term of 5 years. (As Per BSE Announcement dated on 18.08.2023)
16-May-2023	24-May-2023	Accounts	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the company will be meeting on Wednesday May 242023 inter-alia to consider the following: 1. Audited Standalone Financial Results of the company for the quarter and year ended March 31 2023. Further with reference to our earlier intimation March 30 2023 we wish to inform that in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Code of Conduct for Insiders of the Company the trading window will re-open from May 30 2023 onwards. Request you to kindly take the same on your record Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve Pursuant to our earlier intimation dated May 16 2023 regarding intimation of Board meeting on Wednesday, May 24,2023. We would like to further inform the Exchange that we shall inter-alia consider the following in addition to Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2023 1. Consideration and proposed recommendation of Final dividend. As per our earlier intimation the trading window shall re-open from May 30 2023 (As Per BSE Announcement Dated on 17.05.2023) In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on May 24, 2023 has transacted the following business: 1) Approved audited standalone results for the quarter and period ended March 31st, 2023; 2) Recommended the payment of 0.50 per equity share as Final Dividend for the financial year 2022-23 subject to approval of shareholders in the Annual General Meeting. (As Per BSE Announcement Dated on 24.05.2023)
27-Jan-2023	13-Feb-2023	Quarterly Results	Quarterly Results Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015, we wish to inform you that the Board of Directors of the company will be meeting on Monday , February 13,2023 inter-alia to consider the following: - 1. Unaudited Standalone Financial Results of the company for the quarter and year ended December 31, 2022. Further, with reference to our earlier intimation December 31, 2022, we wish to inform that, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from February 16, 2023 onwards. Request you to kindly take the same on your record. (As Per BSE Announcement dated on 27.01.2023) In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on February 13th 2023has transacted the following business: Approved unaudited standalone results for the quarter and period ended December 31st, 2022. The Board meeting commenced by 04:45 P.M and ended by 6:30 P.M (As Per BSE Announcement dated on 13.02.2023) Pursuant to Regulation 30(2) read with Schedule III Part A Para 7 of SEBI (Listing Obligation and Disclosures Requirements) 2015, The board of Directors in its meeting held on 13.02.2023, subsequent to the recommendation of Nomination and Remuneration committee, have appointed Perumalsamy Mahendran holding (DIN: 06680557) as an Additional Director classified as an Independent Director with effect from 13.02.2023 subject to approval of shareholders either through Extra-ordinary General Meeting or Postal ballot. (As per BSE Announcement Dated on 14/02/2023) Please find enclosed herewith the copy of Newspaper Advertisement published on February 14th and February 15th, 2023 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on February 13, 2023. (As Per BSE Announcement dated on 15.02.2023)
05-Nov-2022	14-Nov-2022	Accounts	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the company will be meeting on Monday November 142022 inter-alia to consider the following: - 1. Unaudited Standalone Financial Results of the company for the quarter and year ended September 30 2022. Further with reference to our earlier intimation September 29 2022 we wish to inform that in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Code of Conduct for Insiders of the Company the trading window will re-open from 17th November 2022 onwards Please find enclosed herewith the copy of Newspaper Advertisement published on November 15th and November 16th, 2022 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on November 14, 2022. In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held onNovember 14th2022 has transacted the following business: Approved unaudited standalone results for the quarter and period ended September 30, 2022. The Board meeting commenced by 04:30 P.M and ended 07:05 by P.M (As Per BSE Announcement Dated on 16/11/2022)
30-Jul-2022	09-Aug-2022	Quarterly Results	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the company will be meeting on Tuesday August 092022 inter-alia to consider the following: - 1. Unaudited Standalone Financial Results of the company for the quarter and year ended June 30 2022. Further with reference to our earlier intimation June 30 2022 we wish to inform that in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 and the Code of Conduct for Insiders of the Company the trading window will re-open from August 12 2022 onwards. Request you to kindly take the same on your record. In terms of Regulation 30 of SEBI Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on August 09 2022 has inter-alia transacted the following businesses 1. Approved the unaudited financial statements (standalone) for the quarter ended June 30, 2022 prepared pursuant to Regulation 33 of the Listing Regulations.The figures were reviewed by the Audit Committee at their meeting held on August 09 2022 We request you to please take the same on your record. In terms of Regulation 30 of SEBI Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on August 09 2022 has inter-alia transacted the following businesses 1. Approved the unaudited financial statements (standalone) for the quarter ended June 30, 2022 prepared pursuant to Regulation 33 of the Listing Regulations.The figures were reviewed by the Audit Committee at their meeting held on August 09 2022 We request you to please take the same on your record. (As Per BSE Announcement Dated on 09.08.2022)
16-May-2022	25-May-2022	Accounts	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 inter alia to consider and approve 1. Audited Standalone Financial Results of the company for the quarter and year ended March 31 2022. 2. Consideration and proposed recommendation of Final Dividend Final dividend of Rs0.50 per share recommended by the board subject to approval by the Shareholders in the Annual General Meeting (As Per BSE Announcement Dated on 25.05.2022) With reference to the captioned subject matter and pursuant to Regulation 30 (6) of the Listing Regulations read with Para A of Part A of Schedule III of the said regulations, we are delighted to inform that on recommendation of Nomination & Remuneration committee, the Board of Directors of the Company in its meeting held on Wednesday has appointed Ramanujam Reghunathan (Membership Number- FCA-024458) as the Chief Financial Officer of the Company with effect from May 25 2022. As per the provisions of Section 203 of the Companies Act 2013 read with relevant applicable rules Mr. Ramanujam Reghunathan shall be a whole time key managerial personnel of the company. (As Per BSE Announcement dated on 26.05.2022) We are pleased to inform that the Final dividend recommended by the Board of Directors in its meeting held on 25.05.2022 has been approved by the Shareholders in the 25thAnnual General meeting held on Thursday 22nd September 2022. The Final Dividend shall be disbursed within 30 days of the Annual General Meeting to all those shareholders whose name appears in the Register of Beneficial owners maintained by CDSL and NSDL as on 10th September 2022. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with Section 139(2) of Companies Act 2013 read with Rule 3 of Companies (Audit and Auditors) Rules 2014 M/S. Anbarasu and Jalapathi Associates, Chartered Accountants Coimbatore (ICAI Firm Regn.No 010795S) are appointed as the statutory auditors of Lotus Eye Hospital and Institute Limited for a second term of 5 years from the conclusion of 25th Annual General Meeting till the 30th Annual General Meeting. The appointment of M/S Anbarasu and Jalapathi Associates, Chartered Accountants was recommended by the Board of Directors at their meeting held on 25th May 2022. (As per BSE Announcement Dated on 23/9/2022)
05-Feb-2022	14-Feb-2022	Quarterly Results	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Unaudited Standalone financial results of the company for the quarter and the period ended December 31 2021. Approved unaudited standalone results for the quarter and period ended December 31 2021 Pursuant to Regulation 33 of SEBI(LODR) Regulations 2015 we hereby enclose the Unaudited Standalone financial results for the quarter ended December 31 2021 along with limited review report for the period ended December 31 2021. The figures were reviewed by Audit committee in its meeting held on February 14th 2022 and approved by Board of Directors on February 14th 2022 (As per BSE Announcement Dated on 14/02/2022) With reference to the captioned subject matter and pursuant to Regulation 30 (6) of the Listing Regulations read with Para A of Part A of Schedule III of the said regulations, we are delighted to inform that on recommendation of Nomination & Remuneration committee, the Board of Directors of the Company in its meeting held on Monday February 14th 2022 has appointed Mr M Achuth menon, holding membership number ACS 63980 as Company Secretary and Compliance officer of the company with effect from February 15th 2022. As per the provisions of Section 203 of the Companies Act 2013 read with relevant applicable rules Mr. M Achuth menon shall be a whole time key managerial personnel of the company. (As Per BSE Announcement Dated on 15.02.2022)
21-Oct-2021	13-Nov-2021	Quarterly Results	Quarterly Results Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quarter ended/Half year ended 30th September, 2021; Outcome of Board meeting dated 13/11/2021 Quarterly results (As Per BSE Announcement dated on 13.11.2021)
13-Aug-2021	14-Aug-2021	Quarterly Results	Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve consider and approve Un-Audited Financial Results for the Quarter ended 30th June 2021; outcome of the Board meeting (As Per BSE Announcement Dated on 14/08/2021)

1 2

LOGIN HERE

Lotus Eye Hospital & Institute Ltd

Board Meeting